Related Experiment Video
Updated: Dec 9, 2025
07:50
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
3.0K
Thrombus in Transit: Extract or Dissolve?
Vishal R Dhulipala1,2, Bolajoko O Fayoda1, Htoo Kyaw2,3
1Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.
Cureus
|September 9, 2020
Summary
Thrombus in transit (TIT) is rare but linked to acute pulmonary embolism (PE). The use of thrombolytics in stable patients with a history of intracranial hemorrhage (ICH) requires further investigation.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Thrombus in transit (TIT) is an uncommon diagnosis.
- TIT is frequently identified in patients with acute pulmonary embolism (PE).
Observation:
- The management of TIT in the context of PE is complex.
- Patients with a history of intracranial hemorrhage (ICH) present a unique challenge.
Findings:
- Current guidelines primarily recommend thrombolytics for life-threatening PE presentations.
- The efficacy and safety of thrombolytics in stable TIT/PE patients with prior ICH are not well-defined.
Implications:
- Further research is needed to clarify the role of thrombolytics in this specific patient subgroup.
- Optimal treatment strategies for stable TIT/PE with ICH history require elucidation.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
173
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
173
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
149
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
149
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:30Venous Thrombosis I: Introduction
155
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
155
01:16Clot Retraction and Fibrinolysis
7.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.9K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.8K